Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Engler

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
JMIR Mhealth and Uhealth|March 26, 2021
Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid ReviewElizabeth Houlding, Kedar K V Mate, Kim Engler, et al.
Trials|October 9, 2014
The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trialBertrand Lebouché, Mohammad-Ali Jenabian, Joel Singer, et al.
HIV Medicine|October 10, 2024
The first AI-based Chatbot to promote HIV self-management: A mixed methods usability studyYuanchao Ma, Sofiane Achiche, Gavin Tu, et al.
Healthcare (Basel, Switzerland)|August 29, 2024
Needs-Assessment for an Artificial Intelligence-Based Chatbot for Pharmacists in HIV Care: Results from a Knowledge-Attitudes-Practices SurveyMoustafa Laymouna, Yuanchao Ma, David Lessard, et al.
Plos One|December 30, 2021
Implementation of an electronic patient-reported measure of barriers to antiretroviral therapy adherence with the Opal patient portal: Protocol for a mixed method type 3 hybrid pilot study at a large Montreal HIV clinicKim Engler, Serge Vicente, Yuanchao Ma, et al.
AIDS Patient Care and Stds|August 10, 2021
Barriers and Facilitators Affecting the HIV Care Cascade for Migrant People Living with HIV in Organization for Economic Co-Operation and Development Countries: A Systematic Mixed Studies ReviewAnish K Arora, David Ortiz-Paredes, Kim Engler, et al.
HIV Research & Clinical Practice|January 6, 2021
Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapyBertrand Lebouché, Alexis Yero, Tao Shi, et al.
Journal of Personalized Medicine|February 25, 2022
Understanding the Risks and Benefits of a Patient Portal Configured for HIV Care: Patient and Healthcare Professional PerspectivesDominic Chu, David Lessard, Moustafa A Laymouna, et al.
JMIR Research Protocols|February 13, 2024
Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)Yuanchao Ma, Sofiane Achiche, Marie-Pascale Pomey, et al.
JMIR Research Protocols|July 12, 2022
Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study)David Lessard, Kim Engler, Yuanchao Ma, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
JMIR Mhealth and Uhealth|March 26, 2021
Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid ReviewElizabeth Houlding, Kedar K V Mate, Kim Engler, et al.
Trials|October 9, 2014
The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trialBertrand Lebouché, Mohammad-Ali Jenabian, Joel Singer, et al.
HIV Medicine|October 10, 2024
The first AI-based Chatbot to promote HIV self-management: A mixed methods usability studyYuanchao Ma, Sofiane Achiche, Gavin Tu, et al.
Healthcare (Basel, Switzerland)|August 29, 2024
Needs-Assessment for an Artificial Intelligence-Based Chatbot for Pharmacists in HIV Care: Results from a Knowledge-Attitudes-Practices SurveyMoustafa Laymouna, Yuanchao Ma, David Lessard, et al.
Plos One|December 30, 2021
Implementation of an electronic patient-reported measure of barriers to antiretroviral therapy adherence with the Opal patient portal: Protocol for a mixed method type 3 hybrid pilot study at a large Montreal HIV clinicKim Engler, Serge Vicente, Yuanchao Ma, et al.
AIDS Patient Care and Stds|August 10, 2021
Barriers and Facilitators Affecting the HIV Care Cascade for Migrant People Living with HIV in Organization for Economic Co-Operation and Development Countries: A Systematic Mixed Studies ReviewAnish K Arora, David Ortiz-Paredes, Kim Engler, et al.
HIV Research & Clinical Practice|January 6, 2021
Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapyBertrand Lebouché, Alexis Yero, Tao Shi, et al.
Journal of Personalized Medicine|February 25, 2022
Understanding the Risks and Benefits of a Patient Portal Configured for HIV Care: Patient and Healthcare Professional PerspectivesDominic Chu, David Lessard, Moustafa A Laymouna, et al.
JMIR Research Protocols|February 13, 2024
Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)Yuanchao Ma, Sofiane Achiche, Marie-Pascale Pomey, et al.
JMIR Research Protocols|July 12, 2022
Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study)David Lessard, Kim Engler, Yuanchao Ma, et al.
Pageof 6